vemlidy

Generic: tenofovir alafenamide

Labeler: gilead sciences, inc.
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name vemlidy
Generic Name tenofovir alafenamide
Labeler gilead sciences, inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

tenofovir alafenamide fumarate 25 mg/1

Manufacturer
Gilead Sciences, Inc.

Identifiers & Regulatory

Product NDC 61958-2301
Product ID 61958-2301_175f5d1a-aae9-43d5-b004-65eefec167d4
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA208464
Listing Expiration 2026-12-31
Marketing Start 2016-11-10

Pharmacologic Class

Classes
hepatitis b virus nucleoside analog reverse transcriptase inhibitor [epc] human immunodeficiency virus nucleoside analog reverse transcriptase inhibitor [epc] nucleoside reverse transcriptase inhibitors [moa] nucleosides [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 619582301
Hyphenated Format 61958-2301

Supplemental Identifiers

RxCUI
1858261 1858267
UNII
FWF6Q91TZO

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name vemlidy (source: ndc)
Generic Name tenofovir alafenamide (source: ndc)
Application Number NDA208464 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 25 mg/1
source: ndc
Packaging
  • 30 TABLET in 1 BOTTLE, PLASTIC (61958-2301-1)
source: ndc

Packages (1)

61958-2301-1 30 TABLET in 1 BOTTLE, PLASTIC (61958-2301-1)

Ingredients (1)

tenofovir alafenamide fumarate (25 mg/1)

Linked Drug Pages (1)

VEMLIDY ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "175f5d1a-aae9-43d5-b004-65eefec167d4", "openfda": {"unii": ["FWF6Q91TZO"], "rxcui": ["1858261", "1858267"], "spl_set_id": ["72e6b33c-0351-4070-9172-eeaa186c01d2"], "manufacturer_name": ["Gilead Sciences, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE, PLASTIC (61958-2301-1)", "package_ndc": "61958-2301-1", "marketing_start_date": "20161110"}], "brand_name": "VEMLIDY", "product_id": "61958-2301_175f5d1a-aae9-43d5-b004-65eefec167d4", "dosage_form": "TABLET", "pharm_class": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Nucleosides [CS]"], "product_ndc": "61958-2301", "generic_name": "tenofovir alafenamide", "labeler_name": "Gilead Sciences, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "VEMLIDY", "active_ingredients": [{"name": "TENOFOVIR ALAFENAMIDE FUMARATE", "strength": "25 mg/1"}], "application_number": "NDA208464", "marketing_category": "NDA", "marketing_start_date": "20161110", "listing_expiration_date": "20261231"}